(Q33335764)

25 July 2017

title

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy (English)

1 reference

Adaptive radiation therapy

25 July 2017

main subject

0 references

0 references

J Lewis

1

0 references

author name string

R Laforest

2

1 reference

25 July 2017

T Buettner

3

1 reference

25 July 2017

S Song

4

1 reference

25 July 2017

Y Fujibayashi

5

1 reference

25 July 2017

J Connett

6

1 reference

25 July 2017

M Welch

7

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Proceedings of the National Academy of Sciences of the United States of America

25 July 2017

published in

1 reference

25 July 2017

volume

98

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

1206-1211

1 reference

The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Trials and tribulations: oncological antibody imaging comes to the fore

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Copper radionuclides and radiopharmaceuticals in nuclear medicine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Radioimmunotherapy of small-cell lung cancer xenografts using 131I-labelled anti-NCAM monoclonal antibody 123C3.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

DNA quaternary structure in the radiation sensitivity of human lymphocytes--a proposed role of copper

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Cancer imaging and therapy with radiolabeled antibodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

21 June 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.98.3.1206

Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.98.3.1206

Efficient production of high specific activity 64Cu using a biomedical cyclotron

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.98.3.1206

Copper ion-mediated sensitization of nuclear matrix attachment sites to ionizing radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.98.3.1206

Merrill C. Sosman Lecture. The Auger process: a therapeutic promise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.98.3.1206

Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=14733

Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats

31 October 2018

1 reference

12 December 2020

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

12 December 2020

RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody

1 reference

12 December 2020

THE ANTI-TUMOR ACTIVITY OF 2-KETO-3-ETHOXYBUTYRALDEHYDE BIS(THIOSEMICARBAZONE) AND RELATED COMPOUNDS

1 reference

12 December 2020

Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly-radiolabeled somatostatin analogue

1 reference

12 December 2020

Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso

1 reference

12 December 2020

Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model

1 reference

12 December 2020

1 reference

12 December 2020

Maximum tolerated dose and large tumor radioimmunotherapy studies of 64Cu-labeled monoclonal antibody 1A3 in a colon cancer model

1 reference

12 December 2020

Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model

1 reference

12 December 2020

MIRDOSE: personal computer software for internal dose assessment in nuclear medicine

1 reference

12 December 2020

Experimental radioimmunotherapy

1 reference

12 December 2020

Hydralazine-induced tumor hypoxia: a potential target for cancer chemotherapy

1 reference

12 December 2020

Implantation of colon cancer at trocar sites is increased by low pressure pneumoperitoneum

1 reference

12 December 2020

Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats

1 reference

12 December 2020

Synergistic effects of X-rays and drugs on a human tumor xenograft, GW-39

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.98.3.1206

1 reference

25 July 2017

0 references

1 reference

25 July 2017

1 reference